Explain this page
Arphra AIPlain-English read on Amgen Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.26% | -2.37% | -0.47% | -12.93% | -4.97% | +0.29% | +13.36% | +47.94% | +39.25% | +106.21% | +95393.82% |
Aftermarket
LiveLast trade
$328.95
193 sh
Bid
$327.00
5 sh
Ask
$330.00
55 sh
Spread
$3.000
Sector & industry today
LiveSectors
- Technology+1.59%
- Industrials+1.50%
- Energy+1.40%
- Basic Materials+1.36%
- Utilities+0.94%
- Consumer Cyclical+0.45%
- Real Estate+0.37%
- Consumer Defensive+0.28%
- Financial Services+0.05%
- Healthcare-0.26%
- Communication Services-0.39%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-0.07%
- Hardware, Equipment & Parts+5.17%
- Computer Hardware-4.64%
- REIT - Office+4.28%
- Communication Equipment+4.02%
- Electronic Gaming & Multimedia-3.94%
- Real Estate - Services+3.82%
- Agricultural - Machinery+3.64%
- Auto - Parts+3.58%
- Oil & Gas Energy+3.45%
- Information Technology Services+3.19%
- Copper+3.00%
Fair value
Football field →Weighted blend
$2,270.90
+591.80% vs spot
Recommendation
Strong Buy
17 of 19 methods
Method spread
10bull6bear
±5% threshold
Analyst PT consensus: $350.76 (+6.85%)
Total assets
$90.59B
Total debt
$54.6B
Cash & equiv
$9.13B
Operating CF
$9.96B
Free cash flow
$8.1B
Buybacks
$0
Analyst view
DB · price_targets + analyst_gradesConsensus target
$350.76
+6.85% upside
Low
$185.00
Median
$355.00
High
$432.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Amgen Inc. (AMGN) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 13, 2026
- AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCEprnewswire.com·May 07, 2026
- Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?247wallst.com·May 04, 2026
- Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Knowzacks.com·May 04, 2026
- Amgen to invest additional $300 million to boost US manufacturing footprintreuters.com·May 04, 2026
- Amgen's Q1 Earnings Top Estimates, 16 Drugs Deliver Double-Digit Gainszacks.com·May 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $8.62B | $1.82B | $3.34 |
| Q4 Dec 2025 | $9.9B | $1.33B | $2.45 |
| Q3 Sep 2025 | $9.56B | $3.22B | $5.93 |
| Q2 Jun 2025 | $9.17B | $1.43B | $2.65 |
| Q1 Mar 2025 | $8.15B | $1.73B | $3.20 |
| Q4 Dec 2024 | $9.09B | $627M | $1.16 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Grygiel Nancy A. officer: SVP & CCO | Sell | 1,237 | $400.45K | May 04, 2026 |
Santos Esteban officer: EVP, Operations | Sell | 24,291 | $9.21M | Feb 26, 2026 |
Busch Matthew C. officer: VP, Finance & CAO | Sell | 1,000 | $375.79K | Feb 19, 2026 |
Grygiel Nancy A. officer: SVP & CCO | Sell | 1,639 | $552.77K | Nov 20, 2025 |
Gordon Murdo officer: EVP, Global Commercial Ops | Sell | 6,879 | $2.32M | Nov 12, 2025 |
Khosla Rachna officer: SVP, Business Development | Sell | 890 | $299.26K | Nov 12, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $36.74B | $10.68B | $7.71B | $14.23 | +20.99% |
| FY 2024 | $33.42B | $7.26B | $4.09B | $7.56 | +12.24% |
| FY 2023 | $28.19B | $7.9B | $6.72B | $12.49 | +23.83% |
| FY 2022 | $26.32B | $9.57B | $6.55B | $12.11 | +24.89% |
| FY 2021 | $25.98B | $7.64B | $5.89B | $10.28 | +22.68% |